Abstract
Proteoglycans located in basement membranes, the nanostructures underling epithelial and endothelial layers, are unique in several respects. They are usually large, elongated molecules with a collage of domains that share structural and functional homology with numerous extracellular matrix proteins, growth factors and surface receptors. They mainly carry heparan sulfate side chains and these contribute not only to storing and preserving the biological activity of various heparan sulfate-binding cytokines and growth factors, but also in presenting them in a more Ȍactive configurationȍ to their cognate receptors. Abnormal expression or deregulated function of these proteoglycans affect cancer and angiogenesis, and are critical for the evolution of the tumor microenvironment. This review will focus on the functional roles of the major heparan sulfate proteoglycans from basement membrane zones: perlecan, agrin and collagen XVIII, and on their roles in modulating cancer growth and angiogenesis.
Similar content being viewed by others
References
Abdollahi, A., Hahnfeldt, P., Maercker, C., Gröne, H.-J., Debus, J., Ansorge, W., Folkman, J., Hlatky, L., and Huber, P.E. (2004). Endostatin’s antioangiogenic signaling network. Mol. Cell l3, 649–663.
Adatia, R., Albini, A., Carlone, S., Giunciuglio, D., Benelli, R., Santi, L., and Noonan, D.M. (1998). Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Ann. Oncol. 8, 1257–1261.
Adkins, J.N., Varnum, S.M., Auberry, K.J., Moore, R.J., Angell, N.H., Smith, R.D., Springer, D.L., and Pounds, J.G. (2002). Toward a human blood serum proteome. Analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteom. 1, 947–955.
Arikawa-Hirasawa, E., Watanabe, E., Takami, H., Hassell, J.R., and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nature Genet. 23, 354–358.
Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., and Yayon, A. (1994). Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79, 1005–1013.
Aviezer, D., Iozzo, R.V., Noonan, D.M., and Yayon, A. (1997). Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol. Cell. Biol. 17, 1938–1946.
Baerwald-De La Torre, K., Winzen, U., Halfter, W., and Bixby, J.L. (2004). Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin. J. Neurochem. 90, 50–61.
Batmunkh, E., Tátrai, P., Szabó, E., Lódi, C., Holczbauer, A., Páska, C., Kupcsulik, P., Kiss, A., Schaff, Z., and Kovalszky, I. (2007). Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Hum. Pathol. 38, 1508–1515.
Bezakova, G., and Rüegg, M.A. (2003). New insights into the roles of agrin. Nature Rev. Mol. Cell Biol. 4, 295–308.
Bix, G., and Iozzo, R.V. (2005). Matrix revolutions: “tails” of basement-membrane components with angiostatic functions. Trends Cell Biol. 15, 52–60.
Bix, G., and Iozzo, R.V. (2008). Novel interactions of perlecan: Unraveling perlecan’s role in angiogenesis. Microsc. Res. 71, 339–348.
Bix, G., Fu, J., Gonzalez, E., Macro, L., Barker, A., Campbell, S., Zutter, M.M., Santoro, S.A., Kim, J.K., Hook, M., et al. (2004). Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through the α2β1 integrin. J. Cell Biol. 166, 97–109.
Bix, G., Castello, R., Burrows, M., Zoeller, J.J., Weech, M., Iozzo, R.A., Cardi, C., Thakur, M.T., Barker, C.A., Camphausen, K.C., et al. (2006). Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J. Natl. Cancer Inst. 98, 1634–1646.
Bix, G., Iozzo, R.A., Woodall, B., Burrows, M., McQuillan, A., Campbell, S., Fields, G.B., and Iozzo, R.V. (2007). Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the α2β1 integrin receptor. Blood 109, 3745–3748.
Burgess, R.W., Dickman, D.K., Nunez, L., Glass, D.J., and Sanes, J.R. (2002). Mapping sites responsible for interactions of agrin with neurons. J. Neurochem. 83, 271–284.
Cailhier, J.-F., Sirois, I., Raymond, M.-A., Lepage, S., Laplante, P., Brassard, N., Prat, A., Iozzo, R.V., Pshezhetsky, A.V., and Hebert, M.-J. (2008). Caspase-3 activation triggers extracellular release of cathepsin L and endorepellin proteolysis. J. Biol. Chem. 283, 27220–27229.
Chang, J.W., Kang, U.-B., Kim, D.H., Yi, J.K., Lee, J.W., Noh, D.-Y., Lee, C., and Yu, M.-H. (2008). Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin. Appl. 2, 23–32.
Clamp, A.R., and Jayson, G.C. (2005). The clinical potential of antiangiogenic fragments of extracellular matrix proteins. Br. J. Cancer 93, 967–972.
Cohen, I.R., Murdoch, A.D., Naso, M.F., Marchetti, D., Berd, D., and Iozzo, R.V. (1994). Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res. 54, 5771–5774.
Costell, M., Gustafsson, E., Aszodi, A., Morgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R., and Fassler, R. (1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109–1122.
Costell, M., Carmona, R., Gustafsson, E., Gonzalez-Iriarte, M., Fassler, R., and Munoz-Chapuli, R. (2002). Hyperplastic conotruncal endo-cardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91, 158–164.
Denzer, A.J., Sculthess, T., Fauser, C., Schumacher, B., Kammerer, R.A., Engel, J., and Ruegg, M.A. (1998). Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO J. 17, 335–343.
Dhanabal, M., Ramchandran, R., Waterman, M.J., Lu, H., Knebelmann, B., Segal, M., and Sukhatme, V.P. (1999). Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721–11726.
Donahue, J.E., Berzin, T.M., Rafii, M.S., Glass, D.J., Yancopoulos, G.D., Fallon, J.R., and Stopa, E.G. (1999). Agrin in Alzheimer’s disease: Altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc. Natl. Acad. Sci. USA 96, 6468–6472.
Dong, S., Cole, G.J., and Halfter, W. (2003). Expression of collagen xViii and localization of its glycosaminoglycan attachment sites. J. Biol. Chem. 278, 1700–1707.
Elamaa, H., Snellman, A., Rehn, M., Autio-Harmainen, H., and Pihlajaniemi, T. (2003). Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif. Matrix Biol. 22, 427–442.
Farach-Carson, M.C., and Carson, D.D. (2007). Perlecan - a multi- functional extracellular proteoglycan scaffold. Glycobiology 17, 897–905.
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B.R., and Delaisse, J.(2000). Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486, 247–251.
Fukai, N., Eklund, L., Marneros, A.G., Oh, S.P., Keene, D.R., Tamarkin, L., Niemela, M., Ilves, M., Li, E., Pihlajaniemi, T., et al. (2002). Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535–1544.
Fuki, I., Iozzo, R.V., and Williams, K.J. (2000). Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism. J. Biol. Chem. 275, 25742–25750.
Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P., and Sanes, J.R. (1996). Defective neuromuscular synaptogenesis in agrin-deficient mice. Cell 85, 525–535.
Gesemann, M., Brancaccio, A., Schumacher, B., and Ruegg, M.A. (1998). Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J. Biol. Chem. 273, 600–605.
Ghiselli, G., Eichstetter, I., and Iozzo, R.V. (2001). A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor. Biochem. J. 359, 153–163.
Gianazza, E., Wait, R., Begum, S., Eberini, I., Campagnoli, M., Labo, S., and Galliano, M. (2007). Mapping the 5-50-kDa fraction of human amniotic fluid proteins by 2-DE and ESI-MS. Proteomics Clin. Appl. 1, 167–175.
Gonzalez, E.M., Reed, C.C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D.S., and Iozzo, R.V. (2005). BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080–7087.
González-Iriarte, M., Carmona, R., Pérez-Pomares, J.M., Macías, D., Costell, M., and Munoz-Chápuli, R. (2003). Development of the coronary arteries in a murine model of transposition of great arteries. J. Mol. Cell. Cardio. 35, 795–802.
Grenache, D.G., Zhang, Z., Wells, L.E., Santoro, S.A., Davidson, J.M., and Zutter, M.M. (2006). Wound healing in the α2β1 integrin-deficient mouse: altered keratinocyte biology and dys-regulated matrix metalloproteinase expression. J. Invest. Dermatol. 127, 455–466.
Groffen, A.J.A., Buskens, C.A.F., van Kuppevelt, T.H., Veerkamp, J.H., Monnens, L.A.H., and van den Heuvel, L.P.W.J. (1998). Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur. J. Biochem. 254, 123–128.
Grønborg, M., Kristiansen, T.Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O.N., Hruban, R.H., Goggins, M.G., et al. (2006). Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteom. 5, 157–171.
Halfter, W., Dong, S., Schurer, B., and Cole, G.J. (1998). Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273, 25404–25412.
Handler, M., Yurchenco, P.D., and Iozzo, R.V. (1997). Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210, 130–145.
Hassell, J.R., Yamada, Y., and Arikawa-Hirasawa, E. (2003). Role of perlecan in skeletal development and diseases. Glycoconj. J. 19, 263–267.
Hilgenberg, L.G.W., Su, H., Gu, H., O’Dowd, D.K., and Smith, M.A. (2006). α3Na+/K+-ATPase is a neuronal receptor for agrin. Cell 125, 359–369.
Hurskainen, M., Eklund, L., Hägg, P.O., Fruttiger, M., Sormunen, R., IIves, M., and Pihlajaniemi, T. (2005). Abnormal maturation of the retinal vasculature in type xVlII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII. FASEB J. 19, 1564–1666.
Iozzo, R.V. (1994). Perlecan: a gem of a proteoglycan. Matrix Biol. 14, 203–208.
Iozzo, R.V. (1998). Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67, 609–652.
Iozzo, R.V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nature Rev. Mol. Cell Biol. 6, 646–656.
Iozzo, R.V., and Murdoch, A.D. (1996). Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10, 598–614.
Iozzo, R.V., and San Antonio, J.D. (2001). Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108, 349–355.
Iozzo, R.V., Cohen, I.R., Grassel, S., and Murdoch, A.D. (1994). The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302, 625–639.
Iozzo, R.V., Pillarisetti, J., Sharma, B., Murdoch, A.D., Danielson, K.G., Uitto, J., and Mauviel, A. (1997). Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-p via a nuclear factor 1-binding element. J. Biol. Chem. 272, 5219–5228.
Kadenhe-Chiweshe, A., Papa, J., McCrudden, K.W., Frischer, J., Bae, J.-O., Huang, J., Fisher, J., Lefkowitch, J.H., Feirt, N., Rudge, J., et al. (2008). Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol. Cancer Res. 6, 1–9.
Karumanchi, S.A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabai, M., Hanai, J.-C., Venkataraman, G., Shriver, Z., et al. (2001). Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7, 811–822.
Kim, Y.-M., Hwang, S., Kim, Y.-M., Pyun, B.-J., Kim, T.-Y., Lee, S.-T., Gho, Y.S., and Kwon, Y.-G. (2002). Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277, 27872–27879.
Kim, N., Stiegler, A.L., Cameron, T.O., Hallock, P.T., Gomez, A.M., Huang, J.H., Hubbard, S.R., Dustin, M.L., and Burden, S.J. (2008). Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135, 334–342.
Klein, G., Conzelmann, S., Beck, S., Timpl, R., and Muller, C.A. (1995). Perlecan in human bone marrow: a growth-factor presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol. 14, 457–465.
Krishna, J., Shah, Z.A., Merchant, M., Klein, J.B., and Gozal, D. (2006). Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med. 7, 221–227.
Kuo, C.J., LaMontagne, K.R., Garcia-Cardena, G., Ackley, B.D., Kalman, D., Park, S., Christofferson, R., Kamihara, J., Ding, Y.-H., Lo, K.-M., et al. (2001). Oligomerization-dependent regulationof motility and morphogenesis by the collagen XVIII NC1/endostatin domain. J. Cell Biol. 152, 1233–1246.
Laplante, P., Raymond, M.A., Gagnon, G., Vigneault, N., Sasseville, A.M., Langelier, Y., Bernard, M., Raymond, Y., and Hebert, M.-J. (2005). Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J. Immunol. 174, 5740–5749.
Laplante, P., Raymond, M.-A., Labelle, A., Abe, J.-I., Iozzo, R.V., and Hebert, M.-J. (2006). Perlecan proteolysis induces α2β1 integrin and src-family kinases dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J. Biol. Chem. 281, 30383–30392.
Li, Q., and Olsen, B.R. (2004). Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am. J. Pathol. 165, 415–424.
Lin, W., Burgess, R.W., Dominguez, B., Pfaff, S.L., Sanes, J.R., and Lee, K.-F. (2001). Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410, 1057–1064.
Lin, S., Maj, M., Bezakova, G., Magyar, J.P., Brenner, H.R., and Ruegg, M.A. (2008). Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice. Proc. Natl. Acad. Sci. USA 105, 11406–11411.
Marneros, A.G., and Olsen, B.R. (2005). Physiological role of collagen XVIII and endostatin. FASEB J. 19, 716–728.
Marneros, A.G., Keene, D.R., Hansen, U., Fukai, N., Moulton, K., Goletz, P.L., Moiseyev, G., Pawlyk, B.S., Halfter, W., Dong, S., et al. (2004). Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J. 23, 89–99.
Marneros, A.G., She, H., Zambarakji, H., Hashizume, H., Connolly, E.J., Kim, I., Gragoudas, E.S., Miller, J.W., and Olsen, B.R. (2007). Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 21, 3809–3818.
Mathiak, M., Yenisey, C., Grant, D.S., Sharma, B., and Iozzo, R.V. (1997). A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. Cancer Res. 57, 2130–2136.
Matsumoto-Miyai, K., Sokolowska, E., Zurlinden, A., Gee, C.E., Luscher, D., Hettwer, S., Wolfel, J., Ladner, A.P., Ster, J., Gerber, U., et al. (2009). Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell 136, 1161–1171.
Menzel, O., Bekkeheien, R.C., Reymond, A., Fukai, N., Boye, E., Kosztolanyi, G., Aftimos, S., Deutsch, S., Scott, H.S., Olsen, B.R., et al. (2004). Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum. Mutat. 23, 77–84.
Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J., Whitelock, J., and Iozzo, R.V. (2000). The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275, 7095–7100.
Mongiat, M., Otto, J., Oldershaw, R., Ferrer, F., Sato, J.D., and Iozzo, R.V. (2001). Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. J. Biol. Chem. 276, 10263–10271.
Mongiat, M., Sweeney, S., San Antonio, J.D., Fu, J., and Iozzo, R.V. (2003). Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238–4249.
Moulton, K.S., Olsen, B.R., Sonn, S., Fukai, N., Zurakowski, D., and Zeng, X. (2004). Loss of collagen XVIII enhances neovasculari zation and vascular permeability in atherosclerosis. Circulation 110, 1330–1336.
Nitkin, R.M., Smith, M.A., Magill, C., Fallon, J.R., Yao, Y.-M.M., Wallace, B.G., and McMahan, U.J. (1987). Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J. Cell Biol. 105, 2471–2478.
Nugent, M.A., and Iozzo, R.V. (2000). Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32, 115–120.
Nugent, M.A., Nugent, H.M., Iozzo, R.V., Sanchack, K., and Edelman, E.R. (2000). Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc. Natl. Acad. Sci. USA 97, 6722–6727.
Nyberg, P., Xie, L., and Kalluri, R. (2005). Endogenous inhibitors of angiogenesis. Cancer Res. 65, 3967–3979.
Oda, O., Shinzato, T., Ohbayashi, K., Takai, I., Kunimatsu, M., Maeda, K., and Yamanaka, N. (1996). Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin. Chim. Acta 255, 119–132.
Oh, S.P., Kamagata, Y., Muragaki, Y., Timmons, S., Ooshima, A., and Olsen, B.R. (1994a). Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl. Acad. Sci. USA 91, 4229–4233.
Oh, S.P., Warman, M.L., Seldin, M.F., Cheng, S.-D., Knoll, J.H.M., Timmons, S., and Olsen, B.R. (1994b). Cloning of cDNA and genomic DNA encoding human type xVlII collagen and localization of the a1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19, 494–499.
O’Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285.
O’Riordan, E., Orlova, T.N., Mendelev, N., Patschan, D., Kemp, R., Chander, P.N., Hu, R., Hao, G., Gross, S.S., Iozzo, R.V., et al. (2008). Urinary proteomic analysis of chronic renal allograft nephropathy. Proteomics Clin. Appl. 2, 1025–1035.
Raymond, M.-A., Desormeaux, A., Laplante, P., Vigneault, N., Filep, J.G., Landry, K., Pshezhetsky, A.V., and Hebert, M.-J. (2004). Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on vascular smooth muscle cells. FASEB J. 18, 705–707.
Rehn, M., Hintikka, E., and Pihlajaniemi, T. (1994). Primary structure of the a1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the a1(XVIII) chain with its homologue, the a1 (XV) collagen chain. J. Biol. Chem. 269, 13929–13935.
Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C.R., Pihlajaniemi, T., Alitalo, K., and Vuori, K. (2001). Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98, 1024–1029.
Reif, R., Sales, S., Hettwer, S., Dreier, B., Gisler, C., Wolfel, J., Luscher, D., Zurlinden, A., Stephan, A., Ahmed, S., et al. (2007). Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. FASEB J. 21, 3468–3478.
Reiland, J., Sanderson, R.D., Waguespack, M., Barker, S.A., Long, R., Carson, D.D., and Marchetti, D. (2004). Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J. Biol. Chem. 279, 8047–8055.
Robinson, C.J., Mulloy, B., Gallagher, J.T., and Stringer, S.E. (2006). VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281, 1731–1740.
Rossi, M., Morita, H., Sormunen, R., Airenne, S., Kreivi, M., Wang, L., Fukai, N., Olsen, B.R., Tryggvason, K., and Soininen, R. (2003). Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J. 22, 236–245.
Saarela, J., Ylikarppa, R., Rehn, M., Purmonen, S., and Pihlajaniemi, T. (1998). Complete primary structure of two variant forms of 512 Basement Membrane Proteoglycans in Cancer and Angiogenesis human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol. 16, 319–328.
Sasaki, T., Fukai, N., Mann, K., Gohring, W., Olsen, B.R., and Timpl, R. (1998). Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249–4256.
Sauter, B.V., Martinet, O., Zhang, W.-J., Mandeli, J., and Woo, S.L.C. (2001). Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 97, 4802–4807.
Savoré, C., Zhang, C., Muir, C., Liu, R., Wyrwa, J., Shu, J., Zhau, H.E., Chung, L.W., Carson, D.D., and Farach-Carson, M.C. (2005). Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clin. Exp. Metastasis 22, 377–390.
Scotton, P., Bleckmann, D., Stebler, M., Sciandra, F., Brancaccio, A., Meier, T., Stetefeld, J., and Ruegg, M.A. (2006). Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. J. Biol. Chem. 281, 36835–36845.
Senger, D.R., Perruzzi, C.A., Streit, M., Koteliansky, V.E., de Fougerolles, A.R., and Detmar, M. (2002). The a1p1 and α2β1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160, 195–204.
Seppinen, L., Sormunen, R., Soini, Y., Elamaa, H., Heljasvaara, R., and Pihlajaniemi, T. (2008). Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol. 27, 535–546.
Sharma, B., Handler, M., Eichstetter, I., Whitelock, J., Nugent, M.A., and Iozzo, R.V. (1998). Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J. Clin. Invest. 102, 1599–1608.
Shichiri, M., and Hirata, Y. (2001). Antiangiogenesis signals by endostatin. FASEB J. 15, 1044–1053.
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., and Kalluri, R. (2003). Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by avp3 and a5p1 integrins. Proc. Natl. Acad. Sci. USA 100, 4766–4771.
Sund, M., Zeisberg, M., and Kalluri, R. (2005). Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application. Gastroenterology 129, 2076–2091.
Suzuki, O.T., Sertie, A.L., Der, K.V., Kok, F., Carpenter, M., Murray, J., Czeizel, A.E., Kliemann, S.E., Rosemberg, S., Monteiro, M., et al. (2002). Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am. J. Hum. Genet. 71, 1320–1329.
Sweeney, S.M., DiLullo, G., Slater, S.J., Martinez, J., Iozzo, R.V., Lauer-Fields, J.L., Fields, G.B., and San Antonio, J.D. (2003). Angiogenesis in collagen I requires α2β1 ligation of a GFP*GER sequence and possible p38 MAPK activation and focal adhesion disassembly. J. Biol. Chem. 278, 30516–30524.
Tátrai, P., Dudás, J., Batmunkh, E., Máthé, M., Zalatnai, A., Schaff, Z., Ramadori, G., and Kovalszky, I. (2006). Agrin, a novel basement membrane component in human rat and liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab. Invest. 86, 1149–1160.
Thadikkaran, L., Crettaz, D., Siegenthaler, M.A., Gallot, D., Sapin, V., Iozzo, R.V., Queloz, P.A., Schneider, P., and Tissot, J.D. (2005). The role of proteomics in the assessment of premature rupture of fetal membranes. Clin. Chim. Acta 360, 27–36.
Tran, P.-K., Tran-Lundmark, K., Soininen, R., Tryggvason, K., Thyberg, J., and Hedin, U. (2004). Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ. Res. 94, 550–558.
Tsangaris, G.T., Karamessinis, P., Kolialexi, A., Garbis, S.D., Antsaklis, A., Mavrou, A., and Fountoulakis, M. (2006). Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6, 4410–4419.
Utriainen, A., Sormunen, R., Kettunen, M., Carvalhaes, L.S., Sajanti, E., Eklund, L., Kauppinen, R., Kitten, G.T., and Pihlajaniemi, T. (2004). Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Human Mol. Gen. 13, 2089–2099.
Verbeek, M.M., Otte-Holler, I., van den Born, J., van den Heuvel, L.P.W.J., David, G., Wesseling, P., and de Waal, R.M. (1999). Agrin is a major heparan sulfate proteogl can accumulating in Alzheimer’s disease brain. Am. J. Pathol. 155, 2115–2125.
Vuadens, F., Benay, C., Crettaz, D., Gallot, D., Sapin, V., Schneider, P., Binevenut, W.-V., Lémery, D., Quadroni, M., Dastugue, B., et al. (2003). Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 3, 1521–1525.
Warth, A., Kröger, S., and Wolburg, H. (2004). Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol. 107, 311–318.
West, L., Govindraj, P., Koob, T.J., and Hassell, J.R. (2006). Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate. J. Orthop. Res. 24, 1317–1326.
Whitelock, J.M., and Iozzo, R.V. (2005). Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev. 105, 2745–2764.
Whitelock, J.M., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. J. Biol. Chem. 271, 10079–10086.
Whitelock, J.M., Graham, L.D., Melrose, J., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A. (1999). Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol. 18, 163–178.
Whitelock, J.M., Melrose, J., and Iozzo, R.V. (2008). Diverse cell signaling events modulated by perlecan. Biochemistry 47, 11174–11183.
Wickström, S.A., Alitalo, K., and Keski-Oja, J. (2005). Endostatin signaling and regulation of endothelial cell-matrix interactions. Adv. Cancer Res. 94, 197–229.
Winzen, U., Cole, G.J., and Halfter, W. (2003). Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. J. Biol. Chem. 278, 30106–30114.
Witmer, A.N., van den Born, J., Vrensen, G.F.J.M., and Schlingemann, R.O. (2001). Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Curr. Eye Res. 22, 190–197.
Woodall, B.P., Nystrom, A., Iozzo, R.A., Eble, J.A., Niland, S., Krieg, T., Eckes, B., Pozzi, A., and Iozzo, R.V. (2008). Integrin α2β1 is the required receptor for endorepellin angiostatic activity. J. Biol. Chem. 283, 2335–2343.
Ylikärppä, R., Eklund, L., Sormunen, R., Kontiola, A.I., Utriainen, A., Määttä, M., Fukai, N., and Olsen, B.R. (2003). Lack of type XVIII collagen results in anterior ocular defects. FASEB J. 17, 2257–2259.
Yurchenco, P.D., Amenta, P.S., and Patton, B.L. (2004). Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol. 22, 521–538.
Zatterstrom, U.K., Felbor, U., Fukai, N., and Olsen, B.R. (2000). Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct. Funct. 25, 97–101.
Zhang, J., Wang, Y., Chu, Y., Su, L., Gong, Y., Zhang, R., and Xiong, S. (2006). Agrin is involved in lymphocytes activation that is mediated by a-dystroglycan. FASEB J. 20, 50–58.
Zhang, Z., Ramirez, N.E., Yankeelov, T.E., Li, Z., Ford, L.E., Qi, Y., Pozzi, A., and Zutter, M.M. (2008). α2β1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 111, 1980–1988.
Zhou, Z., Wang, J., Cao, R., Morita, H., Soininen, R., Chan, K.M., Liu, B., Cao, Y., and Tryggvason, K. (2004). Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 64, 4699–4702.
Zoeller, J.J., and Iozzo, R.V. (2008). Proteomic profiling of endorepellin angiostatic activity on human endothelial cells. Proteome Sci. 6, 7.
Zoeller, J.J., McQuillan, A., Whitelock, J., Ho, S.-Y., and Iozzo, R.V. (2008). A central function for perlecan in skeletal muscle and cardiovascular development. J. Cell Biol. 181, 381–394.
Zorick, T.S., Mustacchi, Z., Bando, S.Y., Zatz, M., Moreira-Filho, C.A., Olsen, B., and Passos-Bueno, M.R. (2001). High serum endostatin levels in Down syndrome: Implications for improved treatment and prevention of solid tumors. Eur. J. Hum. Genet. 9, 811–814.
Zweers, M.C., Davidson, J.M., Pozzi, A., Hallinger, R., Janz, K., Quondamatteo, F., Leutgeb, B., Krieg, T., and Eckes, B. (2007). Integrin α2β1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J. Invest. Dermatol. 127, 467–478.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Iozzo, R.V., Zoeller, J.J. & Nyström, A. Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis. Mol Cells 27, 503–513 (2009). https://doi.org/10.1007/s10059-009-0069-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-009-0069-0